Percheron Therapeutics (PER.AU) Q4 2021 Earnings

23FebExpected
Q2 2020
Q4 2020
Q2 2021
Q4 2021
-0.01
-0.01
-0
0

Details

Expected EPS
N/A
Actual EPS
-0.01
Surprise EPS
-0.01
Surprise Percent
+∞%

Description

Percheron Therapeutics (PER.AU) has reported earnings of -0.01 per share for Q4 2021.

0 Comments

Share your thoughts